Semaglutide
PLASTIC
Novo Nordisk · Phase 3 · Not yet recruiting · Enrollment 120
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Pubertal Adolescent - Continuous Treatment | Obesity or overweight | n/r | n/r | n/r | n/r |
| Pubertal Adolescent - Early Treatment Cessation | Obesity or overweight | n/r | n/r | n/r | n/r |
| Post-Pubertal Adolescent - Continuous Treatment | Obesity or overweight | n/r | n/r | n/r | n/r |
| Post-Pubertal Adolescent - Early Treatment Cessation | Obesity or overweight | n/r | n/r | n/r | n/r |
| Adult - Continuous Treatment | Obesity or overweight | n/r | n/r | n/r | n/r |
| Adult - Early Treatment Cessation | Obesity or overweight | n/r | n/r | n/r | n/r |